ArticleTherapeutic advances in neurological disorders2020

PPMS onset upon adalimumab treatment extends the spectrum of anti-TNF-α therapy-associated demyelinating disorders.

Sinah Engel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.